DRUG MAKERS EXPECT STRONGER PROFITS

Several large U.S. drug makers are expected to report improved third-quarter profits, helped by cost cuts, the Medicare drug benefit and growing sales of newer products. But generic competition and management changes have challenged some companies.

Yahoo Finance (http://biz.yahoo.com/ap/061009/drug_makers_outlook.html?.v=1)